miRNA‑22‑3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1

  • 0Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.

|

|

Summary

This summary is machine-generated.

MicroRNA-22-3p, a molecule implicated in cancer, is decreased in nasopharyngeal carcinoma (NPC). Its overexpression suppresses NPC cell viability and migration by targeting FOXP1, suggesting its therapeutic potential.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biochemistry

Background

  • Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in specific geographic regions.
  • MicroRNA (miRNA)-22-3p plays a role in tumorigenesis, but its function in NPC progression is not fully understood.

Purpose Of The Study

  • To investigate the effects of miRNA-22-3p overexpression on nasopharyngeal carcinoma (NPC) cell viability and migration.
  • To elucidate the underlying molecular mechanisms, including the interaction with forkhead box protein 1 (FOXP1).

Main Methods

  • Cell viability and migration assays (Transwell, wound healing, CCK-8) were performed on HK-1 NPC cells.
  • Epithelial-mesenchymal transition markers (E-cadherin, vimentin, N-cadherin) were assessed via Western blot.
  • A dual-luciferase reporter assay was used to confirm the interaction between miRNA-22-3p and FOXP1.

Main Results

  • miRNA-22-3p expression was significantly lower in NPC tissues and cell lines compared to normal controls.
  • Overexpression of miRNA-22-3p inhibited HK-1 cell viability and migration.
  • miRNA-22-3p directly targets FOXP1, and FOXP1 overexpression reversed the inhibitory effects of miRNA-22-3p.

Conclusions

  • Decreased miRNA-22-3p levels are associated with NPC progression.
  • miRNA-22-3p suppresses NPC cell viability and migration, potentially through the regulation of FOXP1.
  • miRNA-22-3p represents a potential therapeutic biomarker for nasopharyngeal carcinoma.

Related Concept Videos

MicroRNAs 01:22

3.0K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Experimental RNAi 02:15

6.0K

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...